Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An integrin-targeted non-viral vector for pulmonary gene therapy.

R G Jenkins1, S E Herrick, Q H Meng

  • 1Centre for Cardiopulmonary Biochemistry and Respiratory Medicine, Royal Free and University College Medical School, University College London, Rayne Institute, London, UK.

Gene Therapy
|March 1, 2000
PubMed
Summary

A novel non-viral gene delivery system targets the lung for gene therapy, showing efficient gene transfer without inflammation. This breakthrough offers significant potential for treating severe respiratory diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Exploring the characteristics of the <i>Pulse Classic</i> revised by the medical book bureau in the Northern Song Dynasty].

Zhonghua yi shi za zhi (Beijing, China : 1980)·2026
Same author

[Atypical pertussis: challenges in diagnosis, prevention and response strategies].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025
Same author

[Clinical features and prognosis of patients with peripheral neuropathy with systemic light chain amyloidosis].

Zhonghua yi xue za zhi·2025
Same author

The association between fibrotic diseases and treatment-resistant hypertension in England.

European journal of preventive cardiology·2025
Same author

Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP<sub>3</sub>.

Cancer gene therapy·2023
Same author

[Recompensation of complications in patients with hepatitis B virus-related decompensated cirrhosis treated with entecavir antiviral therapy].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2023

Area of Science:

  • Pulmonary Medicine
  • Gene Therapy
  • Biotechnology

Background:

  • Current viral vectors for gene therapy have limitations for therapeutic use.
  • Severe respiratory diseases require effective gene delivery methods.

Purpose of the Study:

  • To develop and evaluate an integrin-targeted, non-viral gene delivery system for pulmonary gene transfer.
  • To assess the efficiency and safety of this novel vector compared to existing methods.

Main Methods:

  • Development of an integrin-targeted, non-viral vector.
  • Delivery of the lacZ reporter gene to the lung.
  • Comparison of transfection efficiency with adenoviral vectors and cationic liposomes.
  • Evaluation of repeated administration and inflammatory response.

Related Experiment Videos

Main Results:

  • The non-viral vector successfully delivered the lacZ reporter gene to lung cells.
  • Transfection efficiency in bronchial epithelium and parenchymal cells was comparable to adenoviral vectors.
  • The novel vector demonstrated higher efficiency than cationic liposomes.
  • Repeated administration resulted in further gene expression without inducing inflammation.

Conclusions:

  • The integrin-targeted, non-viral gene delivery system is effective for pulmonary gene transfer.
  • This system offers advantages over current vectors, including reduced inflammation and potential for repeat dosing.
  • The developed vector shows considerable promise for in vivo targeted gene therapy for respiratory diseases.